Actionable Clarity in Respiratory Diagnostics
When patient volume is high and symptoms overlap, diagnostic certainty is paramount. Discover a workflow engineered to deliver reliable answers, faster.
Navigating Diagnostic Uncertainty During Peak Respiratory Season
During peak seasons, healthcare professionals face immense pressure to accurately differentiate between multiple respiratory pathogens like Influenza A/B, RSV, and SARS-CoV-2, which often present with indistinguishable symptoms. This diagnostic challenge is compounded by the risk of co-infections, where a single patient may harbor multiple viruses simultaneously, complicating treatment pathways.
The need for rapid, accurate, and reliable results is critical. Delays or inaccuracies caused by inconsistent testing tools—the `Black Box Risk`—can lead to suboptimal patient management, increased healthcare costs, and contribute to wider community transmission. Clinics and laboratories require a solution that provides not just a result, but a trusted and verifiable starting point for every clinical decision.
An Optimized Workflow, Powered by Certainty
Our approach integrates seamlessly into your existing processes, enhancing efficiency and confidence at every step. From initial screening to confirmatory testing, reOpenTest provides a tiered solution to match your specific clinical needs.
Patient Triage
Rapidly screen symptomatic patients at the point of care.
Multiplex Testing
Utilize high-performance combination tests to differentiate between multiple common respiratory pathogens with a single sample.
Confident Decision
Enable prompt, evidence-based treatment and patient management decisions.
The Foundation of Confidence: Powered by NomoFlow™
The exceptional consistency and reliability of our multiplex assays, critical for accurate differential diagnosis during peak season, is not an accident. It is the direct result of our NomoFlow™ manufacturing platform, which ensures batch-to-batch variation of less than 3% CV. This is how we engineer certainty into your workflow, from the first test to the millionth.
The Evidence for a Better Workflow
The NomoFlow™ Advantage: Why Our Tests Are More Reliable
Before evaluating clinical results, understand the source of their reliability. Our NomoFlow™ platform's precision engineering minimizes the inconsistencies that create the 'Black Box Risk' in other tests. The data proves it.
Comparative analysis shows NomoFlow™-produced tests exhibit significantly lower batch-to-batch variation, a key indicator of consistent performance.
The Building Blocks of Your Solution
Respiratory Combo 4-Plex Antigen Test
Simultaneously detect and differentiate SARS-CoV-2, Influenza A/B, and RSV from a single nasal swab.
COVID-19 Antigen Rapid Test Pro
High-sensitivity rapid test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen.
Upgrade Your Diagnostic Strategy
Let our experts help you design and implement a respiratory testing workflow that delivers the certainty you and your patients deserve.
Speak with a Clinical Application Specialist